- ►nih.gov HD Caldwell, H Wood, D Crane, R Bailey, RB … - Journal of Clinical Investigation, 2003 - Am Soc Clin Investig We previously reported that laboratory reference strains of Chlamydia
trachomatis differing in infection organotropism correlated with inactivating
mutations in the pathogen's tryptophan synthase (trpBA) genes. Here, we ... Cited by 93 - Related articles - BL Direct - All 7 versions
AW Solomon, MJ Holland, MJ Burton, SK West … - The Lancet, 2003 - Elsevier Trachoma accounts for 10–15% of global blindness. 1 It is caused by ocular
infection with Chlamydia trachomatis and mainly affects poor, marginalised, and
displaced people living in the hot dry regions of the world. Blindness from ... Cited by 81 - Related articles - All 10 versions
DCW Mabey, AW Solomon, A Foster - The Lancet, 2003 - Elsevier Trachoma is the most common infectious cause of blindness. It is caused by
ocular serovars of Chlamydia trachomatis. Transmission is favoured in poor
communities, where crowding is common and access to water and sanitation ... Cited by 82 - Related articles - All 9 versions
SO Holm, HC Jha, RC Bhatta, JSP Chaudhary, … - Bulletin of the World Health Organization, 2001 - SciELO Public Health Keywords: Azithromycin/supply and distribution; Trachoma/drug therapy;
Comparative study; Randomized controlled trials; Nepal (source: MeSH). ... Mots
clés: Azithromycine/ressources et distribution; Trachome/chimiothérapie; ... Cited by 38 - Related articles - Cached - All 12 versions
- ►nih.gov RJC Bowman, H Faal, M Myatt, R Adegbola, A … - British Journal of Ophthalmology, 2002 - bjo.bmj.com Conclusions: Despite the overall decline in trachoma in the Gambia, patients
with both minor and major trichiasis remain at risk of developing corneal
opacity. Active trachomatous inflammation and additional infection with ... Cited by 33 - Related articles - BL Direct - All 8 versions
SK West - Progress in retinal and eye research, 2004 - Elsevier Trachoma is the leading infectious cause of blindness worldwide. The World
Health Organization (WHO) estimated that approximately 5.9 million persons are
blind or have severe vision-loss as a result of trachoma, and another 10 ... Cited by 30 - Related articles - All 5 versions
A Hoechsmann, N Metcalfe, S Kanjaloti, H … - Neuro-Ophthalmology, 2001 - Informa Pharma Science Correspondence and reprint requests to: Dr. Paul Courtright BC Centre Epidemiol.
& Int. Ophthalmology Dept. Ophthalmology Univ. British Columbia St. Paul's
Hospital 1081 Burrard Street Vancouver, BC Canada V6Z 1Y6 Fax: +1-604-806- ... Cited by 28 - Related articles - BL Direct - All 5 versions
- ►nih.gov SL Batt, BM Charalambous, AW Solomon, C … - Antimicrobial agents and chemotherapy, 2003 - Am Soc Microbiol Community distribution of azithromycin has an important role to play in trachoma
control. Previous studies have suggested that this may increase the prevalence
of macrolide-resistant Streptococcus pneumoniae. S. pneumoniae was isolated ... Cited by 26 - Related articles - BL Direct - All 13 versions
- ►nih.gov - Free from Publisher BD Gaynor, JD Chidambaram, V Cevallos, Y … - British Journal of Ophthalmology, 2005 - bjo.bmj.com Methods: All children aged 1–10 years were offered either single dose oral
azithromycin treatment (20 mg/kg) or a course of topical 1% tetracycline
ointment, depending on the area. Treatment was given annually for 3 years. ... Cited by 24 - Related articles - BL Direct - All 10 versions
